Pfizer: New cancer pill gives hope, new strategy
World BusinessAug 31, 2011
TRENTON, New Jersey (AP) ― Pfizer Inc.’s just-approved drug Xalkori, the first new medicine in more than six years for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists and Pfizer executives said Tuesday.The drug was approved Friday